Recent Updates
Recently added Catalysts
LNTH Positive Sentiment

Lantheus to Host Second Quarter 2026 Earnings Conference Call and Webcast on August 6, 2026, at 8:00 a.m. Eastern Time

Thursday, July 23, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Lantheus Holdings, Inc. has announced a conference call and webcast scheduled for August 6, 2026, at 8:00 a.m. ET. The call will focus on discussing the company's financial results for the second quarter and providing a business update. This event reflects the company's commitment to keeping stakeholders informed.
Price reaction · baseline $104.61 (2026-07-22 close) · hit pre-market · clean, no other LNTH news in the window
day 0 close
-0.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Lantheus is actively engaging with investors through a conference call.
  • The scheduled call indicates transparency about financial results.
  • The timing allows for timely updates on business performance.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+39%
120-day peak, hindsight
Typical move
2.3%
average across 6 past catalysts
Lead asset
18F-DCFPyL
Phase 3 · Prostate Cancer

Full Press Release Details

BEDFORD, Mass. , July 23, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, August 6, 2026 , to discuss its financial results and provide a business update for the second quarter of 2026.
To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events . To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.
A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.
About Lantheus Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years. For more information, visit www.lantheus.com .
Contacts:

Frequently Asked Questions

When is the Lantheus Q2 2026 earnings call?

The earnings call is scheduled for August 6, 2026, at 8:00 a.m. ET.

What will Lantheus discuss during the call?

Lantheus will discuss its financial results and provide a business update.

How can I access the Lantheus earnings call?

The earnings call will be available via conference call and webcast.

ShareAdd on Google
Tags: LNTH Lantheus earnings call financial results business update
Last updated: Jul 23, 2026

Biotech snapshot

Cash runway
$593M liquidity · $0M/mo burn
Low dilution risk
Lead asset
18F-DCFPyLPhase 3
Prostate Cancer →

Catalyst track record

+39%
best trade around LNTH's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for LNTH.

See every catalyst's timing & PoA →